Aditxt, Inc.ADTXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Aditxt, Inc. is a clinical-stage biotechnology company focused on immunology. It develops targeted therapies to promote immune tolerance for patients with autoimmune diseases and organ transplant recipients, plus immune monitoring technologies. Its main markets are in North America, with expansion efforts underway in other global developed healthcare regions.